Your session is about to expire
← Back to Search
Hormone Therapy for Menopause-Related Weight Gain (BEAM Trial)
BEAM Trial Summary
This trial is studying how menopause affects weight gain and risk for diseases like cardiovascular disease and diabetes.
BEAM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBEAM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BEAM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of heart disease.I am a healthy woman going through or past menopause and open to hormone treatment.I am currently using glucocorticoids or medications affecting glucocorticoid metabolism.You have a body mass index (BMI) that is higher than 39 kg/m2.My liver tests are higher than normal.I have severe bone loss with a t-score below -2.0.I am a healthy woman, willing to undergo hormone treatment for a study, and fit the age and hormonal criteria.You smoke cigarettes or use vape devices more than twice a week.I am 6 months to 7 years post-menopause with an FSH level over 30 IU/L.You drink more than 14 alcoholic drinks per week on a regular basis.I use marijuana or THC more than three times a week.My blood pressure is controlled and does not exceed 150/90 mmHg.My thyroid is not functioning properly, but I might be eligible if it's treated.I have had breast cancer or other cancers related to estrogen.I have experienced unusual bleeding from my vagina.I have had blood clots in my veins or lungs before.I am allergic to degarelix, estradiol, or medroxyprogesterone.
- Group 1: Postmenopausal: GnRH antagonist + placebo
- Group 2: Postmenopausal: placebo + placebo
- Group 3: Postmenopausal: GnRH antagonist + estradiol
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you provide an overview of prior investigations surrounding Estrogen Product?
"Presently, there are 120 trials analyzing Estrogen Product with 25 of those currently in their final phase. The majority are situated in Duarte California but the medication is being tested at 3485 different sites around the world."
To what degree can Estrogen Product be deleterious to patients?
"Estrogen Product has been approved, which is reflected in its score of 3 for safety."
What is the total recruitment capacity for this clinical trial?
"That is correct. According to information hosted on clinicaltrials.gov, the trial was first launched in September 2019 and has since been actively recruiting patients for participation. A total of 57 participants are sought at a single medical centre."
To whom is the opportunity to participate in this clinical trial offered?
"This clinical trial necessitates that applicants be between 40 and 65 years old, suffer from obesity, and have visceral fat to qualify. The research is hoping to accrue a total of 57 participants."
What medical maladies is Estrogen Product commonly administered to alleviate?
"Estrogen Product is commonly employed to treat women with no menstrual period in the past 6 months, as well as hypoestrogenism, vasomotor symptoms related to menopause, and breast cancer."
Are any new participants being accepted into this experiment at present?
"Affirmative. According to clinicaltrials.gov, the research is actively seeking participants and was originally published on September 24th 2019 before being modified lastly on October 19th 2022. 57 individuals from a single study location are required for this medical trial."
What positive outcomes is this trial hoping to manifest?
"This medical trial, to be assessed over a Baseline and week 12 time period, intends to determine the alteration in Oral Cortisone Challenge (OCC) Area Under the Curve (AUC). Secondary goals include an evaluation of deviation in resting energy expenditure (REE), flow-mediated dilation (FMD), as well as visceral fat area (VFA). REE is an index of metabolism while at rest; conversely FMD measures vascular health. Finally VFA elucidates how much fat is stored within the abdominal region."
Does this clinical trial permit elderly individuals to participate?
"As laid out by the inclusion criteria for this trial, patients between 40 and 65 years old are eligible. Conversely, there are 33 studies targeting those under 18 while 362 trials offer assistance to people beyond retirement age."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger